2m 2m 2m 2m 2m 2m 2m
Enzolytics (ENZC)
OTC
$0.0006+$0.00005 (+9.09%)
Price as of Jul 31, 2026- $2.9MMarket Cap
- -14.29%1-Year Change
- BiotechnologyIndustry
Enzolytics (ENZC)
$0.0006+$0.00005 (+9.09%)
ENZC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.00 | ||
Change | +$0.00005 (+9.09%) | ||
Open | $0.00 | ||
High | $0.00 | ||
Low | $0.00 | ||
Previous Close | $0.00 | ||
Volume | 1,257,316 | ||
30-Day Average Volume | 3,608,798 | ||
1-Week Change | 0.00% | ||
1-Month Change | -40.00% | ||
1-Year Change | -14.29% | ||
3-Year Change | -98.62% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 4.8B | ||
Total Assets | $112,053.00 | ||
Market Cap | $2.9M | ||
Enterprise Value | $3.3M | ||
Period: QTR TTM FY | |||
Revenue | $15,350.00 | ||
Net Income | -$221,241.00 | ||
Free Cash Flow | N/A | ||
EBIT | -$214,028.00 | ||
EBITDA | -$210,937.00 | ||
Net Working Capital | N/A | ||
EPS | -$5.00 | ||
Enterprise Value/EBITDA | -16 | ||
Enterprise Value/Revenue | 214 | ||
P/B | -4 | ||
P/E | -0 | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||